Table 1.
Confidence domains | Median (IQR) confidence scores | p value1 | ||
---|---|---|---|---|
All respondents n = 35 |
<5 years of experience n = 13 |
>5 years of experience n = 22 |
||
Therapeutic target range | 2 (1–2) | 1 (1–3) | 2 (1–3) | 0.04 |
Timing of first blood concentration | 2 (1–2) | 1 (1–3) | 2 (1–4) | 0.02 |
General advice to prescribers | 2 (2–2) | 2 (1–3) | 2 (1–4) | 0.32 |
Loading dose | 2 (2–2) | 2 (1–3) | 2 (1–4) | 0.13 |
Amending dosing based on TDM | 2 (2–3) | 2 (1–3) | 2 (1–3) | 0.10 |
Frequency of blood concentrations | 2 (2–3) | 2 (1–4) | 2 (1–3) | 0.83 |
Administration rate | 2 (2–3) | 3 (1–5) | 2 (1–4) | 0.13 |
Management of infusion related reactions | 3 (2–3) | 3 (1–5) | 3 (1–5) | 0.36 |
1 = strongly agree, 2 = agree, 3 = not sure, 4 = disagree, 5 = strongly disagree
TDM therapeutic drug monitoring, IQR interquartile range, 1 Using Mann-Whitney